Invitation to Roche’s virtual event on key ophthalmology data presented at the Angiogenesis 2021 Meeting Mittwoch, 27. Januar 2021 - 10:01

Investor Update

Invitation to Roche's virtual event on key ophthalmology data presented at the Angiogenesis 2021 Meeting

b7a301c2-a891-45a7-beda-09a00517015b

We are pleased to invite investors and analysts to participate in our virtual event on Tuesday, 16 February, 2021, highlighting Roche data presented at the virtual Angiogenesis, Exudation, and Degeneration 2021 Meeting, from 12th to 13th February.

16:30 – 17:30 CET / 15:30 - 16:30 GMT

10:30 – 11:30 am EST / 7:30 – 8:30 am PST

The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). Detailed programme information will follow.

Access to virtual event (pre-registration required)

Please pre-register for our webinar here*.

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.

A replay of the event will be available via > ir.roche.com

*privacy notice

Best regards,
Karl Mahler Head of Investor Relations and Roche Group Planning	Lisa Tuomi Investor Relations Officer

Roche Investor Relations
Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com
Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com	Jon Kaspar Bayard Phone: +41 61 68-83894 e-mail: jon_kaspar.bayard@roche.com

Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com	Dr. Lisa Tuomi Phone: +1 650 467 8737 e-mail: tuomi.lisa@gene.com

Attachment

210120_IR_Angiogenesis Invitation_en